Vancomycin-resistant enterococci (VRE) first appeared in Europe during the 1980s. It rapidly spread to North America by the 1990s.
More than 50% of E. faecium in the United States are VRE.
E. faecalis tends to be susceptible to vancomycin.
Most frequent form of VRE infection: UTI, followed by catheter line associated bacteremia (i.e hemodialysis, central lines).
Treatment for VRE: daptomycin, linezolid, and tigecycline. Susceptible strains may be treated with ampicillin.
A common finding described on computed tomography (CT) imaging. A disease with a peribronchovascular distribution…
It is not clearly understood why patients with pulmonary hypertension (PH) develop pericardial effusions. However,…